These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3969688)

  • 1. Studies on the toxicity of the antitumour agent N-methylformamide in mice.
    Langdon SP; Chubb D; Gescher A; Hickman JA; Stevens MF
    Toxicology; 1985 Feb; 34(2):173-83. PubMed ID: 3969688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of N-methylformamide in mice--I. Relationship to glutathione status.
    Pearson PG; Gescher A; Harpur ES
    Biochem Pharmacol; 1987 Feb; 36(3):381-4. PubMed ID: 3814177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.
    Harpur ES; Langdon SP; Fathalla SA; Ishmael J
    Cancer Chemother Pharmacol; 1986; 16(2):139-47. PubMed ID: 3948299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the mechanism of hepatotoxicity of the antitumour agent N-methylformamide in mice.
    Whitby H; Gescher A; Levy L
    Biochem Pharmacol; 1984 Jan; 33(2):295-302. PubMed ID: 6704151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of the relationship between the hepatotoxicity and the metabolism of N-alkylformamides.
    Kestell P; Threadgill MD; Gescher A; Gledhill AP; Shaw AJ; Farmer PB
    J Pharmacol Exp Ther; 1987 Jan; 240(1):265-70. PubMed ID: 3806387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051).
    Cooksey PG; Gate EN; Gescher A; Hickman JA; Langdon SP; Stevens MF
    Biochem Pharmacol; 1983 Oct; 32(20):3037-43. PubMed ID: 6639672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy.
    Langdon SP; Hickman JA; Gescher A; Stevens MF; Chubb D; Vickers LM
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):745-52. PubMed ID: 4018116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methylformamide: antitumour activity and metabolism in mice.
    Gescher A; Gibson NW; Hickman JA; Langdon SP; Ross D; Atassi G
    Br J Cancer; 1982 Jun; 45(6):843-50. PubMed ID: 7201320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity and metabolism of the hepatotoxin N-methylformamide and related formamides in mouse hepatocytes.
    Shaw AJ; Gescher A; Mráz J
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):162-70. PubMed ID: 3413793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and hepatotoxicity of N,N-dimethylformamide, N-hydroxymethyl-N-methylformamide, and N-methylformamide in the rat.
    Van den Bulcke M; Rosseel MT; Wijnants P; Buylaert W; Belpaire FM
    Arch Toxicol; 1994; 68(5):291-5. PubMed ID: 8085939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of diethyldithiocarbamate on the hepatotoxic action and antitumor activity of N-methylformamide in mice.
    Masuda Y; Nakayama N; Yasoshima M
    Jpn J Pharmacol; 1986 Apr; 40(4):541-50. PubMed ID: 3016389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of N-methylformamide-induced hepatotoxicity and metabolism in rats and mice.
    Tulip K; Nicholson JK; Timbrell JA
    Adv Exp Med Biol; 1986; 197():941-50. PubMed ID: 3766303
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of sodium ascorbate, menadione sodium bisulfite or pyridoxal hydrochloride on the toxic and antineoplastic action of N-methylformamide in P 388 leukemia or M 5076 sarcoma in mice.
    Osswald H; Herrmann R; Youssef M
    Toxicology; 1987 Feb; 43(2):183-91. PubMed ID: 3810660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity of N-methylformamide in mice--II. Covalent binding of metabolites of [14C]-labelled N-methylformamide to hepatic proteins.
    Pearson PG; Gescher A; Harpur ES; Threadgill MD
    Biochem Pharmacol; 1987 Feb; 36(3):385-90. PubMed ID: 3814178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the mechanism of hepatotoxicity of N-methylformamide in mice: effects on calcium sequestration in hepatic microsomes and mitochondria and on hepatic plasma membrane potential.
    Whitby H; Chahwala SB; Gescher A
    Biochem Biophys Res Commun; 1984 Dec; 125(2):712-8. PubMed ID: 6517921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative hepatotoxicity and metabolism of N-methylformamide in rats and mice.
    Tulip K; Timbrell JA
    Arch Toxicol; 1988; 62(2-3):167-76. PubMed ID: 3196150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
    Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
    Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of N-methylformamide on artificial and spontaneous metastases from a murine hepatocarcinoma.
    Tofilon PJ; Vines CM; Milas L
    Br J Cancer; 1987 Mar; 55(3):239-43. PubMed ID: 3567058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methylformamide affects spontaneous metastases of 3LL lines and increases natural killer activity of tumor-bearing mice.
    Greco C; Del Bufalo D; Giannarelli D; Marangolo M; Fuggetta MP; Bonmassar E; Zupi G
    Clin Exp Metastasis; 1990; 8(2):153-63. PubMed ID: 2317955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of tumor and normal tissue radioresponse in mice by N-methylformamide.
    Iwakawa M; Milas L; Hunter N; Tofilon PJ
    Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):55-60. PubMed ID: 3804817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.